XML 61 R20.htm IDEA: XBRL DOCUMENT v2.4.0.8
EARNINGS PER SHARE AND STOCKHOLDERS' EQUITY: (Tables)
9 Months Ended
Dec. 31, 2013
EARNINGS PER SHARE AND STOCKHOLDERS' EQUITY:  
Schedule of reconciliation of the numerator and denominator of basic and diluted earnings per share

A reconciliation of the numerator and denominator of basic and diluted earnings per share is shown below (in thousands, except per share amounts):

 

 

 

For the quarter ended
December 31

 

For the nine months ended
December 31

 

 

 

2013

 

2012

 

2013

 

2012

 

Basic earnings per share:

 

 

 

 

 

 

 

 

 

Net earnings

 

$

15,067

 

$

14,449

 

$

38,026

 

$

44,020

 

Net gain (loss) attributable to noncontrolling interest

 

 

(76

)

(60

)

(349

)

Net earnings attributable to Acxiom

 

$

15,067

 

$

14,525

 

$

38,086

 

$

44,369

 

 

 

 

 

 

 

 

 

 

 

Basic weighted-average shares outstanding

 

75,009

 

74,103

 

74,155

 

75,195

 

 

 

 

 

 

 

 

 

 

 

Basic earnings per share:

 

 

 

 

 

 

 

 

 

Net earnings

 

$

0.20

 

$

0.19

 

$

0.51

 

$

0.59

 

Net loss attributable to noncontrolling interest

 

 

 

 

 

Net earnings attributable to Acxiom

 

$

0.20

 

$

0.20

 

$

0.51

 

$

0.59

 

 

 

 

 

 

 

 

 

 

 

Diluted earnings per share:

 

 

 

 

 

 

 

 

 

Basic weighted-average shares outstanding

 

75,009

 

74,103

 

74,155

 

75,195

 

Dilutive effect of common stock options, warrants, and restricted stock as computed under the treasury stock method

 

2,830

 

1,775

 

2,301

 

1,792

 

Diluted weighted-average shares outstanding

 

77,839

 

75,878

 

76,456

 

76,987

 

 

 

 

 

 

 

 

 

 

 

Diluted earnings per share:

 

 

 

 

 

 

 

 

 

Net earnings

 

$

0.19

 

$

0.19

 

$

0.50

 

$

0.57

 

Net loss attributable to noncontrolling interest

 

 

 

 

 

Net earnings attributable to Acxiom

 

$

0.19

 

$

0.19

 

$

0.50

 

$

0.58

 

Schedule of antidilutive options, warrants and restricted stock units excluded from computation of earnings per share

Options, warrants and restricted stock units that were outstanding during the periods presented, but were not included in the computation of diluted earnings per share because the effect was antidilutive are shown below (in thousands, except per share amounts):

 

 

 

For the quarter ended
December 31

 

For the nine months ended
December 31

 

 

 

2013

 

2012

 

2013

 

2012

 

Number of shares outstanding under options, warrants and restricted stock units

 

549

 

4,752

 

1,400

 

7,872

 

Range of exercise prices for options and warrants

 

$32.85-$62.06

 

$17.76-$62.06

 

$21.46-$62.06

 

$13.10-$62.06

 

Schedule of accumulated balances for each component of other comprehensive income

The accumulated balances for each component of other comprehensive income are as follows (dollars in thousands):

 

 

 

December 31,
2013

 

March 31,
2013

 

Foreign currency translation

 

$

13,197

 

$

12,175

 

Unrealized loss on interest rate swap

 

 

(752

)

 

 

$

13,197

 

$

11,423